International Patent: NOVEL ENGINEERED LYASE AND USE THEREOF

GENEVA, July 6 -- SHANGHAI SCIZENG MEDICAL TECHNOLOGY CO., LTD. filed a patent application (CN2025/146144) for “NOVEL ENGINEERED LYASE AND USE THEREOF”. With publication no. WO/2026/139061, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 9/88

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....